Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07755046
Repetitive Transcranial Magnetic Stimulation for Alcohol Use DisorderTing-Gang ChangCompletedNot Applicable
NCT07755046Completed
Not Applicable
Repetitive Transcranial Magnetic Stimulation for Alcohol Use DisorderTing-Gang Chang
NCT07755098
Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic Neurodevelomental DisordersCentre Hospitalier Universitaire DijonNot Yet RecruitingNot Applicable
NCT07755098Not Yet Recruiting
Not Applicable
Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic...Centre Hospitalier Univer...
NCT07754357
Ultrasound-Guided T2 Erector Spinae Plane Block Versus Intercostobrachial Block in AV Fistula Surgery.Aswan University HospitalEnrolling By InvitationNot Applicable
NCT07754357Enrolling By Invitation
Not Applicable
Ultrasound-Guided T2 Erector Spinae Plane Block Versus Intercostobrachial Block...Aswan University Hospital
NCT07756632
Evaluating the Effectiveness of an AI-powered Physician Assistant in Improving Patients' and Physician's Satisfaction in an Outpatient Setting of a Tertiary Care Hospital.Aga Khan UniversityNot Yet RecruitingNot Applicable
NCT07756632Not Yet Recruiting
Not Applicable
Evaluating the Effectiveness of an AI-powered Physician Assistant in Improving P...Aga Khan University
NCT07756554
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionAmager HospitalRecruitingNot Applicable
NCT07756554Recruiting
Not Applicable
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospi...Amager Hospital
NCT07754669
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedNot Applicable
NCT07754669Completed
Not Applicable
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academ...
NCT07755631
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organization of Southwestern OntarioNot Yet RecruitingNot Applicable
NCT07755631Not Yet Recruiting
Not Applicable
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organiza...
NCT07756281
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic CancerRevolution Medicines, Inc.Not Yet RecruitingPhase 1
NCT07756281Not Yet Recruiting
Phase 1
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pa...Revolution Medicines, Inc...
NCT07756385
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs. Centurion)University Hospital Sveti DuhRecruitingNot Applicable
NCT07756385Recruiting
Not Applicable
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs....University Hospital Sveti...
NCT07756398
Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)University of Texas Southwestern Medical CenterNot Yet RecruitingNot Applicable
NCT07756398Not Yet Recruiting
Not Applicable
Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardi...University of Texas South...
NCT07754903
Basic Trauma Training Programme for Newly Graduated Nurses in Saudi Trauma CentresKing Saud Medical CityNot Yet RecruitingNot Applicable
NCT07754903Not Yet Recruiting
Not Applicable
Basic Trauma Training Programme for Newly Graduated Nurses in Saudi Trauma Centr...King Saud Medical City
NCT07754877
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter StudyPeking University Aerospace Center HospitalNot Yet RecruitingNot Applicable
NCT07754877Not Yet Recruiting
Not Applicable
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combin...Peking University Aerospa...
NCT07754890
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical College HospitalRecruitingPhase 1
NCT07754890Recruiting
Phase 1
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical Coll...
NCT07754734
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter MethylationDongguan People's HospitalNot Yet RecruitingPhase 2
NCT07754734Not Yet Recruiting
Phase 2
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With M...Dongguan People's Hospita...
NCT07755150
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 DiabetesChendu DIAO Pharmaceutical Group CO., LTD.Not Yet RecruitingPhase 2
NCT07755150Not Yet Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects Wi...Chendu DIAO Pharmaceutica...
NCT07755748
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response IncentivesCenters for Disease Control and PreventionNot Yet RecruitingNot Applicable
NCT07755748Not Yet Recruiting
Not Applicable
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Inc...Centers for Disease Contr...
NCT07755332
Association Between Central Sensitization and the Root Mean Square of Successive DifferencesIstanbul Demiroglu Bilim UniversityCompleted
NCT07755332Completed
—
Association Between Central Sensitization and the Root Mean Square of Successive...Istanbul Demiroglu Bilim...
NCT07756619
Neuromuscular Stimulation in the Distal Radius FracturesKirsehir Ahi Evran UniversitesiNot Yet RecruitingNot Applicable
NCT07756619Not Yet Recruiting
Not Applicable
Neuromuscular Stimulation in the Distal Radius FracturesKirsehir Ahi Evran Univer...
NCT07755059
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisMassachusetts General HospitalNot Yet RecruitingNot Applicable
NCT07755059Not Yet Recruiting
Not Applicable
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Asci...Massachusetts General Hos...
Result Breakdown
Not yet recruiting13 (65%)
Completed3 (15%)
Recruiting3 (15%)
Enrolling by invitation1 (5%)
not_applicable15 (75%)
Phase 12 (10%)
Phase 22 (10%)
Not Specified1 (5%)